Primary peritoneal clear cell carcinoma. A case report and literature review

Primary peritoneal clear cell carcinoma. A case report and literature review

Primary peritoneal malignant tumors are exceptional. Among them, clear cell carcinoma is extremely rare, being only thirteen cases previously reported in the literature since 1990. We report a case of a 48-year-old Caucasian woman who was treated at the University General Hospital of Alicante. She c...

Full description

Bibliographic Details
Main Authors:	Gloria Peiro, Sandra Silva-Ortega, Cristina Garcia-Espasa, Manuela Sala-Ferichola, Sandra Perez-Vicente, Elena Castellon-Molla, Josefa Marcos-Sanmartin
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Gynecologic Oncology Reports
Subjects:	Primary peritoneal clear cell carcinoma (PPCCC) NapsinA PD-L1 Prognosis ARID1A
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352578920300175

Similar Items

Sensitivity and prognostic value of thyroid transcription factor-1 and napsin A in primary adenocarcinoma of the lung
by: Patryk Kraiński, et al.
Published: (2020-01-01)

Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas
by: Genova Sylvia N., et al.
Published: (2017-06-01)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
by: Emi Sato, et al.
Published: (2018-06-01)

Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma
by: Pınar BULUTAY, et al.
Published: (2021-01-01)

IMP3 can predict aggressive behaviour of lung adenocarcinoma
by: Beljan Perak Renata, et al.
Published: (2012-11-01)

Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
by: Yu-Chien Lin, et al.
Published: (2020-12-01)

Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma
by: Saira Khalique, et al.
Published: (2021-07-01)

Utility of Napsin-A in diagnosis of non-small cell lung carcinomas and its addition with thyroid transcription factor-1 (TTF-1) in small biopsies of lung: Does it help in morphologically challenging situations?
by: Richa Ranjan, et al.
Published: (2021-01-01)

Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
by: Wei Jiang, et al.
Published: (2018-07-01)

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
by: Gorka Larrinaga, et al.
Published: (2021-02-01)

Correlation of TTF-1 and Napsin A expression in CT-guided percutaneous puncture tissue with the malignant biology of cancer cells
by: Wen-Guo Sun, et al.
Published: (2018-07-01)

<i>CCNE1</i> Is a Putative Therapeutic Target for <i>ARID1A</i>-Mutated Ovarian Clear Cell Carcinoma
by: Naoki Kawahara, et al.
Published: (2021-05-01)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
by: Kazuaki Takahashi, et al.
Published: (2021-04-01)

Diagnostic Value of Immunohistochemistry Panel of P63, CK5/6, TTF1, NapsinA in the Diagnosis of Adenocarcinoma and Squamous Cell Carcinoma of Lung
by: Tahereh Mohsenian Sisakht, et al.
Published: (2020-07-01)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
by: Ie-Ming Shih, et al.
Published: (2010-12-01)

Concordant clear cell “mesonephric” carcinoma of the bladder and lung adenocarcinoma with clear cell features – multiple primaries versus metastatic neoplasms: a case report
by: Sarmad H. Jassim, et al.
Published: (2017-05-01)

Subtyping of Non-Small Cell Lung Carcinomas in Bronchoscopic Biopsies: A Tertiary Care Centre Experience
by: Mihir Mohan Vaidya, et al.
Published: (2018-11-01)

Role of minimal panel immunostaining in accurate diagnosis of lung cancer using small biopsies
by: Manar Ahmed Abdel Rahman, et al.
Published: (2017-04-01)

SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma
by: Marta Wagner, et al.
Published: (2020-11-01)

The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D
by: Samukawa Takuya, et al.
Published: (2012-09-01)

Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A
by: Wen Xiao, et al.
Published: (2017-10-01)

Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies
by: Jill Alldredge, et al.
Published: (2020-12-01)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
by: Xiaonan Zhang, et al.
Published: (2021-04-01)

Molecular Characterization of Muellerian Tumors of the Urinary Tract
by: Nadina Ortiz-Brüchle, et al.
Published: (2021-06-01)

Genetic Alterations in Invasive Breast Carcinoma with a Glycogen-Rich Clear Cell Pattern: A Case Report
by: Carlo De la Sancha, et al.
Published: (2021-03-01)

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
by: Tsukuru Amano, et al.
Published: (2019-07-01)

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
by: Brooke E. Howitt, et al.
Published: (2017-02-01)

Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis
by: Jun-Li Zhao, et al.
Published: (2019-10-01)

Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
by: Huijuan Ge, et al.
Published: (2021-02-01)

Molecular Characteristics of Genes and the Immune Microenvironment of a Rare Chest Malignant Tumor (Pulmonary Clear Cell Sarcoma): A Case Report
by: Xiaoling Xu, et al.
Published: (2021-03-01)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
by: Jie Wang, et al.
Published: (2013-05-01)

Aeromonas sobria peritonitis in a peritoneal dialysis (PD) patient: a case report and review of the literature
by: Panai Song, et al.
Published: (2019-05-01)

Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer
by: Minchul Kim, et al.
Published: (2016-09-01)

Utility of five commonly used immunohistochemical markers TTF‐1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases
by: Grzegorz T Gurda, et al.
Published: (2015-12-01)

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
by: Vadim S. Koshkin, et al.
Published: (2018-01-01)

Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients
by: Qiong Bai, et al.
Published: (2020-01-01)

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction
by: Abiko, Kaoru
Published: (2014)

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
by: Abudureyimujiang Aili, et al.
Published: (2021-08-01)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
by: Su Gao, et al.
Published: (2021-07-01)

The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression
by: Simonetta Buglioni, et al.
Published: (2018-08-01)